PCP 100 Week 6: Neuropharmacology and Special Senses

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/38

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering pharmacology affecting the nervous system (CNS depressants, analgesics, stimulants, antidepressants, antipsychotics) and the functional anatomy of the eyes, ears, and nose from PCP 100 Week 6.

39 Terms

1
New cards

Central Nervous System (CNS) Depressants

A class of drugs that decreases central nervous system activity by reducing the ability of neurons to form action potentials.

2
New cards

Barbiturates

A class of CNS depressants (e.g., phenobarbital, pentobarbital) that induce sedation and suppress seizures by potentiating GABA and directly prolonging the duration that chloride channels stay open.

3
New cards

Benzodiazepines

A class of CNS depressants (e.g., midazolam, alprazolam) used for sedation, seizure suppression, and antianxiety by increasing the frequency of GABA-mediated chloride channel openings.

4
New cards

Paradoxical Agitation

An unexpected, contrary drug reaction where a patient becomes agitated and worked up rather than sedated after receiving benzodiazepines.

5
New cards

Analgesics

A broad class of medications that decreases the ability of pain-detecting neurons and nociceptors to form action potentials in the peripheral and/or central nervous system.

6
New cards

Esters and Amides

Classes of local anesthetics ending in "-caine" (e.g., lidocaine, bupivacaine, procaine) that act as sodium channel blockers to prevent depolarization and nerve signal conduction.

7
New cards

Systemic Toxicity (Local Anesthetics)

A severe adverse effect occurring when local anesthetic drugs block sodium channels in non-target tissues beyond the intended site, affecting muscle movement, the brain, or cardiac function.

8
New cards

Opioids

Analgesic medications (e.g., morphine, fentanyl, hydrocodone) that bind to mu, delta, and kappa receptors to modulate GABA activity and inhibit pain sensation and perception.

9
New cards

Tolerance

A pharmacological state where repeated administration of a drug causes a given dose to become less effective, requiring progressively higher doses to achieve the same therapeutic effect.

10
New cards

NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

Non-opioid medications (e.g., ibuprofen, naproxen, ketorolac) that reduce pain and inflammation by inhibiting the cyclooxygenase (COX) enzyme.

11
New cards

Cyclooxygenase (COX)

An enzyme involved in inflammation and homeostatic functions that, when inhibited by NSAIDs, reduces inflammatory chemical production and dorsal spinal cord excitability.

12
New cards

CNS Stimulants

Medications (e.g., methylphenidate, Adderall, cocaine) that increase central nervous system action potentials by enhancing the release or blocking the reuptake of catecholamines.

13
New cards

Catecholamines

A group of neurotransmitters comprising dopamine, norepinephrine, and epinephrine that activate the body's fight-or-flight response and enhance nervous system activity.

14
New cards

SSRIs (Selective Serotonin Reuptake Inhibitors)

Antidepressant medications that selectively block the reuptake of serotonin into presynaptic neurons, increasing its presence and action in the synaptic cleft.

15
New cards

SNRIs (Selective Norepinephrine Reuptake Inhibitors)

Antidepressant medications that selectively inhibit the reuptake of norepinephrine into presynaptic neurons to sustain its activity in synaptic clefts.

16
New cards

MAOIs (Monoamine Oxidase Inhibitors)

Antidepressants that inhibit monoamine oxidase, preventing the enzymatic breakdown of neurotransmitters and allowing them to persist longer in the synaptic cleft.

17
New cards

Antipsychotics

Medications (e.g., haloperidol, risperidone) used to manage delusions, hallucinations, and schizophrenia by blocking presynaptic dopamine release or postsynaptic dopamine receptor binding.

18
New cards

Tardive Dyskinesia

A motor dysfunction disorder affecting the musculoskeletal and nervous systems that can occur as a side effect of antipsychotic medication use.

19
New cards

Cornea

The clear outer surface layer located at the front of the anterior chamber of the eye through which incoming light enters.

20
New cards

Iris

The colored muscular band in the anterior eye that adjusts its diameter to regulate the size of the pupil and the amount of light entering.

21
New cards

Pupil

The aperture or opening in the center of the iris through which light travels into the interior of the eye.

22
New cards

Lens (Eye)

The internal ocular structure that bends and focuses light so that it falls accurately onto the retina at the posterior part of the eye.

23
New cards

Aqueous Humor

The clear fluid filling the front of the eye that provides nutrients, structural stability, and waste removal without obstructing light.

24
New cards

Vitreous Body

A gelatinous substance filling the posterior chamber of the eye that maintains the eye's shape and provides supportive functions.

25
New cards

Sclera

The tough, outer white protective tissue layer of the eye.

26
New cards

Choroid Layer

The middle, vascularized layer of the eye situated between the outer sclera and the inner retina.

27
New cards

Retina

The innermost, light-sensing neural layer located at the back of the eye that converts photons into action potentials directed toward the optic nerve.

28
New cards

Fovea Centralis

A specialized central retinal area, centered at the macula luteus, with densely packed photoreceptors free of overlying structures that provides maximal visual acuity.

29
New cards

Cones

Cone-shaped retinal photoreceptors specialized for the detection of color.

30
New cards

Rods

Retinal photoreceptors specialized for detecting light intensity and distinguishing bright light from dim light rather than color.

31
New cards

Tympanic Membrane

The eardrum membrane that vibrates in response to environmental sound waves conducted through the external ear canal.

32
New cards

Ossicles

Small middle-ear bones that vibrate at specific frequencies to transmit sound energy mechanically from the tympanic membrane to the cochlea.

33
New cards

Otitis Media

An inflammation or infection occurring within the middle ear that can result in localized pain or impaired hearing.

34
New cards

Cochlea

A coiled, fluid-filled inner ear labyrinth responsible for converting mechanical sound vibrations into action potentials.

35
New cards

Organ of Corti

The functional sensory structure within the cochlea containing microscopic hair cells that convert fluid vibrations into neural impulses.

36
New cards

Basilar Membrane

A membrane within the cochlea that vibrates with sound waves; it is narrow and stiff at the base to detect high frequencies and wider and flexible at the apex to detect low frequencies.

37
New cards

Tectorial Membrane

A tough, fibrous structure in the organ of Corti against which sensory hair cells brush and bend to open ion channels and generate action potentials.

38
New cards

Ethmoid Bone

A skull bone featuring tiny perforations through which olfactory nerve fibers travel; susceptible to shearing damage and loss of smell during traumatic brain injuries.

39
New cards

Olfactory Bulb

An enlarged cranial nerve structure situated above the ethmoid bone that receives scent signals from olfactory receptor axons and relays them to the brain.